Open access
Oct 2026
Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care
LLM can be safely and effectively administered in primary care for children with monogenic FH and already low-dose statins resulted in substantial LDL-C reduction, demonstrating real world applicability of guideline recommendations for early start of treatment in FH in a primary care setting.
R. Schmieder, J. Krefting, S. Arens et al.
· European Heart Journal · 0 citations